GlassScriptPhysician profile
Kevin T Snyder
NPI 1578582391
$11,668.28
in general payments reported to CMS, 2019-2025
58 companies · $2,295 in 2025
The $2,295 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,001 · 2020: $1,183 · 2021: $1,952 · 2022: $1,385 · 2023: $1,950 · 2024: $1,902 · 2025: $2,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,992 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,992.24 |
| Education | $154.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,232.64 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Astellas Pharma US INC | $1,179.50 | 2019-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $1,110.12 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $860.42 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $842.85 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $762.64 | 2019-2025 | Otezla, Repatha, Repatha |
| Glaxosmithkline, LLC. | $668.92 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Corcept Therapeutics | $662.89 | 2019-2025 | Korlym |
| Pfizer INC. | $433.26 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $296.16 | 2021-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $282.02 | 2019-2023 | Tradjenta, Synjardy, Jardiance |
| Kowa Pharmaceuticals America, INC. | $266.27 | 2019-2024 | Seglentis, Livalo, Zoryve |
| Takeda Pharmaceuticals U.S.A., INC. | $250.12 | 2019-2024 | Trintellix, Gattex |
| Exact Sciences Corporation | $249.58 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $192.08 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.